3-9810077-C-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001025930.5(TTLL3):c.71C>A(p.Ser24Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001025930.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TTLL3 | NM_001387446.1 | c.-359C>A | upstream_gene_variant | ENST00000685419.1 | NP_001374375.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ARPC4-TTLL3 | ENST00000397256.5 | c.331-2866C>A | intron_variant | Intron 4 of 11 | 5 | ENSP00000380427.1 | ||||
TTLL3 | ENST00000685419.1 | c.-359C>A | upstream_gene_variant | NM_001387446.1 | ENSP00000510679.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 1238554Hom.: 0 Cov.: 70 AF XY: 0.00 AC XY: 0AN XY: 604186
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.71C>A (p.S24Y) alteration is located in exon 1 (coding exon 1) of the TTLL3 gene. This alteration results from a C to A substitution at nucleotide position 71, causing the serine (S) at amino acid position 24 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.